A detailed history of Great Valley Advisor Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 82,876 shares of ABBV stock, worth $15 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
82,876
Previous 81,215 2.05%
Holding current value
$15 Million
Previous $13.9 Million 17.5%
% of portfolio
0.43%
Previous 0.4%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $272,138 - $331,087
1,661 Added 2.05%
82,876 $16.4 Million
Q2 2024

Jul 16, 2024

BUY
$154.79 - $180.76 $1.43 Million - $1.68 Million
9,270 Added 12.88%
81,215 $13.9 Million
Q1 2024

May 03, 2024

BUY
$159.82 - $182.1 $1.34 Million - $1.53 Million
8,407 Added 13.23%
71,945 $13.1 Million
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $266,393 - $300,021
1,936 Added 3.14%
63,538 $9.85 Million
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $689,190 - $797,839
5,159 Added 9.14%
61,602 $9.18 Million
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $824,874 - $1.03 Million
6,225 Added 12.4%
56,443 $7.6 Million
Q1 2023

May 02, 2023

BUY
$144.61 - $166.54 $1.21 Million - $1.39 Million
8,360 Added 19.97%
50,218 $8 Million
Q4 2022

Jan 31, 2023

SELL
$138.31 - $165.87 $74,272 - $89,072
-537 Reduced 1.27%
41,858 $6.77 Million
Q3 2022

Oct 21, 2022

SELL
$134.21 - $153.93 $319,285 - $366,199
-2,379 Reduced 5.31%
42,395 $5.69 Million
Q2 2022

Jul 19, 2022

BUY
$137.62 - $174.96 $814,985 - $1.04 Million
5,922 Added 15.24%
44,774 $6.86 Million
Q1 2022

Apr 20, 2022

BUY
$131.98 - $163.75 $162,467 - $201,576
1,231 Added 3.27%
38,852 $5.92 Million
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $19,444 - $24,603
-181 Reduced 0.48%
37,621 $4.73 Million
Q3 2021

Oct 14, 2021

BUY
$106.4 - $120.78 $91,397 - $103,750
859 Added 2.33%
37,802 $4.08 Million
Q2 2021

Jul 27, 2021

BUY
$105.21 - $117.21 $559,717 - $623,557
5,320 Added 16.82%
36,943 $4.11 Million
Q1 2021

Apr 20, 2021

BUY
$102.3 - $112.62 $938,091 - $1.03 Million
9,170 Added 40.84%
31,623 $3.42 Million
Q4 2020

Jan 29, 2021

SELL
$80.49 - $108.67 $21,490 - $29,014
-267 Reduced 1.18%
22,453 $2.41 Million
Q3 2020

Oct 21, 2020

BUY
$85.91 - $100.83 $156,356 - $183,510
1,820 Added 8.71%
22,720 $1.99 Million
Q2 2020

Jul 31, 2020

BUY
$73.37 - $98.18 $264,278 - $353,644
3,602 Added 20.82%
20,900 $2.05 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $141,384 - $214,355
2,192 Added 14.51%
17,298 $1.32 Million
Q4 2019

Feb 10, 2020

SELL
$72.13 - $90.25 $134,738 - $168,587
-1,868 Reduced 11.01%
15,106 $1.34 Million
Q3 2019

Oct 25, 2019

BUY
$62.98 - $75.72 $26,577 - $31,953
422 Added 2.55%
16,974 $1.28 Million
Q2 2019

Jul 30, 2019

SELL
$65.7 - $83.98 $265,165 - $338,943
-4,036 Reduced 19.6%
16,552 $1.2 Million
Q1 2019

Apr 26, 2019

BUY
$77.14 - $90.79 $95,499 - $112,398
1,238 Added 6.4%
20,588 $1.66 Million
Q4 2018

Apr 11, 2019

BUY
$77.85 - $96.01 $1.51 Million - $1.86 Million
19,350 New
19,350 $1.75 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Great Valley Advisor Group, Inc. Portfolio

Follow Great Valley Advisor Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.